Quality Improvement in Congenital Heart Surgery

Timothy W Pettitt1,2

  • 1Department of Pediatric Cardiovascular Surgery, Children's Hospital of New Orleans, New Orleans, LA.

Neoreviews
|March 4, 2020
PubMed

Insights

Congenital heart surgery outcomes have improved, but variability persists. Prioritizing quality assurance and improvement is key to enhancing patient care and reducing differences between medical centers.

Area of Science:

  • Pediatric Cardiology
  • Cardiac Surgery
  • Public Health

Background:

  • Congenital heart disease (CHD) presents a significant public health challenge in the US.
  • Surgical outcomes for pediatric CHD have seen substantial improvements over recent decades, with an overall operative mortality rate around 3%.
  • However, considerable interinstitutional variability in outcomes remains, particularly for complex and high-risk pediatric patients.

Purpose of the Study:

  • To highlight the importance of quality assurance and improvement in congenital heart surgery programs.
  • To address the evolving demands of the quadruple aim in healthcare: improving patient experience, population health, cost-effectiveness, and provider satisfaction.
  • To advocate for strategies that reduce interinstitutional outcome variability in pediatric cardiac surgery.

Main Methods:

  • Review of current trends and outcomes in congenital heart surgery.
  • Analysis of factors contributing to interinstitutional variability.
  • Emphasis on quality improvement frameworks within healthcare.

Main Results:

  • Aggregate operative mortality for congenital heart surgery is approximately 3%.
  • Significant disparities in surgical outcomes exist across different institutions.
  • Quality assurance and improvement initiatives are identified as crucial for standardizing care.

Conclusions:

  • Enhanced quality assurance and improvement are essential for optimizing congenital heart surgery programs.
  • Addressing interinstitutional variability is critical for achieving the quadruple aim in pediatric cardiac care.
  • Standardized quality initiatives can lead to better patient outcomes and experiences.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
249
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
215
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
299
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
479
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
861